Zika Virus Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Test Type (Molecular Test, and Serologic Test), End-User and Geography

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Zika virus (ZIKV) infection has been known to be endemic in Africa and Southeast Asia. The consequent viral spread over the Pacific region led to an outbreak in the developed and emerging countries, worldwide. According to the World Health Organization (WHO), about 84 countries/territories are or have been previously infected by ZIKV transmission. There have been major outbreaks of Zika virus infection in Asia-Pacific (particularly India) and South American countries. As per the Centers for Disease Control and Prevention, Mexico, South America, Central, and Sub-Saharan African countries, and several countries in Southeast Asia are the major countries at risk for the growth of Zika virus infection. Thus, the rising prevalence of Zika virus infection is one of the primary factors driving the growth of the market studied, over the forecast period.

The other prominent drivers of the market studied are increasing R&D by biopharmaceutical companies, and technological advancements in diagnostic tests.

Scope of the Report

Zika virus belongs to the flavivirus genus transmitted by Aedes mosquitoes, which bites during the day. The scope of the market includes market segmentation by test type and end-user.

By Test Type
Molecular Test
Serologic Test
By End User
Diagnostics Laboratory
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Serologic Test Segment is Expected to Show Better Growth in the Forecast Years

The Zika Virus Testing market has been segmented based on test type and end-user. The test type is further segmented into Molecular Test and Serologic Test. The serologic test is expected to grow due to their increased preference as they can detect acute as well as late-stage zika virus infection. In addition, emerging rapid detection serological diagnostics offer shorter turnaround time as well as the differential diagnosis of Zika against other flaviviruses. Furthermore, zika in early pregnancy increases risk of birth defects. According to the CDC, birth defects cases were reported in a higher proportion of babies whose mothers were infected with the zika virus during the first trimester of pregnancy. The virus can be transmitted from an infected pregnant woman to a fetus and causes microcephaly and other severe brain anomalies. This has prompted the testing of pregnant women for the Zika virus, further fueling the growth of the market.

Zika Virus Testing Market 1

North America Dominates the Market and is Expected to Follow the Same Trend Over the Forecast Period

North America is expected to dominate the market studied. The growth can be attributed to the rising awareness of the advantages of testing kits. The government organizations, such as the Centers for Disease Control and Prevention (CDC), Pan American Health Organization (PAHO), etc., have been mainly involved in the prevention of Zika virus infection. As per the CDC, About 2 in 20 (10%) babies of women with confirmed Zika virus infection during pregnancy in US states and about 1 in 20 (5%) in US territories had Zika-associated birth defects. The CDC has received funding, to combat the zika outbreak across several territories. In addition, the developed healthcare infrastructure, along with rapid technological advancements by several biopharmaceutical companies in the testing of the zika virus is expected to positively impact the market.

Zika Virus Testing Market 2

Competitive Landscape

The global players in the Zika Virus Testing market are Abbott Laboratories, Altona Diagnostics GmbH, Chembio Diagnostic Systems Inc., ELITechGroup, F. Hoffmann-La Roche Ltd, Genekam, Luminex Corporation, Novacyt Group, Quest Diagnostics and Siemens AG.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Zika Virus Infection

      2. 4.2.2 Increasing R&D by Biopharmaceutical Companies

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Testing Kits

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Test Type

      1. 5.1.1 Molecular Test

      2. 5.1.2 Serologic Test

    2. 5.2 By End User

      1. 5.2.1 Hospital/Clinic

      2. 5.2.2 Diagnostics Laboratory

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Altona Diagnostics GmbH

      3. 6.1.3 Chembio Diagnostic Systems Inc.

      4. 6.1.4 ELITechGroup

      5. 6.1.5 F. Hoffmann-La Roche Ltd

      6. 6.1.6 Genekam

      7. 6.1.7 Luminex Corporation

      8. 6.1.8 Novacyt Group

      9. 6.1.9 Quest Diagnostics

      10. 6.1.10 Siemens AG

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Zika Virus Testing Market market is studied from 2018 - 2026.

The Zika Virus Testing Market is growing at a CAGR of 5.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Abbott Laboratories, F. Hoffmann-La Roche Ltd, Luminex Corporation, Quest Diagnostics, Siemens AG are the major companies operating in Zika Virus Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!